Amdocs (NASDAQ:DOX) Issues FY 2025 Earnings Guidance

Amdocs (NASDAQ:DOXGet Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided EPS guidance of 6.859-7.116 for the period, compared to the consensus EPS estimate of 6.970. The company issued revenue guidance of $4.4 billion-$4.6 billion, compared to the consensus revenue estimate of $4.5 billion. Amdocs also updated its Q2 2025 guidance to 1.670-1.730 EPS.

Amdocs Stock Down 0.6 %

Shares of NASDAQ:DOX traded down $0.53 during midday trading on Tuesday, hitting $86.86. 1,254,157 shares of the company’s stock were exchanged, compared to its average volume of 572,121. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.20 and a quick ratio of 1.20. The stock has a 50 day moving average price of $85.96 and a 200-day moving average price of $86.40. The company has a market cap of $9.81 billion, a PE ratio of 20.49, a price-to-earnings-growth ratio of 1.47 and a beta of 0.71. Amdocs has a 12 month low of $74.41 and a 12 month high of $94.04.

Amdocs (NASDAQ:DOXGet Free Report) last issued its quarterly earnings data on Tuesday, February 4th. The technology company reported $1.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.64 by ($0.19). Amdocs had a return on equity of 18.69% and a net margin of 9.85%. On average, sell-side analysts anticipate that Amdocs will post 6.19 EPS for the current fiscal year.

Amdocs Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st were given a $0.479 dividend. This represents a $1.92 dividend on an annualized basis and a yield of 2.21%. The ex-dividend date was Tuesday, December 31st. Amdocs’s payout ratio is 45.28%.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on DOX. StockNews.com downgraded shares of Amdocs from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, January 14th. Oppenheimer increased their target price on shares of Amdocs from $98.00 to $105.00 and gave the company an “outperform” rating in a research report on Wednesday, November 13th. Finally, Barclays reduced their target price on shares of Amdocs from $113.00 to $111.00 and set an “overweight” rating for the company in a research report on Thursday, November 14th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, Amdocs presently has an average rating of “Moderate Buy” and a consensus target price of $101.20.

Read Our Latest Stock Report on DOX

Amdocs Company Profile

(Get Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Further Reading

Earnings History and Estimates for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.